http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102731485-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b33dd6f3ada81a293d6202f04929e5d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
filingDate 2011-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9d2c950363563ad12e429ec359b471c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_116bed10c8966d316e1a1f2c0a3947b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_942e6f2b972ae9bd01d52a8334658cf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d29f6a4767e04eee1ba3e4d562283a4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f023244f719f4d4ccac1240ea8b49c92
publicationDate 2012-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102731485-A
titleOfInvention 4-(Substituted anilino)quinazoline derivatives and their preparation method, pharmaceutical composition and use
abstract The present invention relates to 4-(substituted anilino)quinazoline derivatives and their preparation method, pharmaceutical composition and application. Specifically, the present invention relates to a compound of formula I or a pharmaceutically acceptable salt or solvate thereof, wherein R 1 , R 2 and R 3 are as defined in the specification and claims. The present invention also relates to the preparation method of the compound of formula I, including its pharmaceutical composition and their pharmaceutical use. The compounds of formula I according to the invention are potent irreversible inhibitors of tyrosine kinases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106068262-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106279045-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105646375-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777656-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777655-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106279045-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104350049-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104710413-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777656-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777655-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104710413-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11008292-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106908523-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106068262-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106908523-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034672-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104774184-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110818618-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104350049-B
priorityDate 2011-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010151710-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467949162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66554567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465087903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID144453545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427750114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427750272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70856339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464963181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66555428

Total number of triples: 55.